Safety Study of SEA-CD40 in Cancer Patients

Clinical Trial ID NCT02376699

PubWeight™ 1.56‹?›

🔗 Visit the ClinicalTrials.gov page for NCT02376699

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Emerging targets in cancer immunotherapy: beyond CTLA-4 and PD-1. Immunotherapy 2015 0.81
2 Immune Checkpoint Modulation in Colorectal Cancer: What's New and What to Expect. J Immunol Res 2015 0.78
Next 100